|
CAMK2D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.197700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.969100E-04 |
| Normal-vs-Stage2 |
1.770460E-02 |
| Normal-vs-Stage3 |
3.408800E-01 |
| Normal-vs-Stage4 |
2.973600E-01 |
| Stage1-vs-Stage2 |
4.871600E-01 |
| Stage1-vs-Stage3 |
4.948500E-02 |
| Stage1-vs-Stage4 |
3.822000E-02 |
| Stage2-vs-Stage3 |
6.536000E-02 |
| Stage2-vs-Stage4 |
8.268400E-02 |
| Stage3-vs-Stage4 |
9.817600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.479700E-03 |
| Normal-vs-AfricanAmerican |
6.404300E-02 |
| Normal-vs-Asian |
2.200000E-01 |
| Caucasian-vs-AfricanAmerican |
9.357400E-01 |
| Caucasian-vs-Asian |
9.068200E-01 |
| AfricanAmerican-vs-Asian |
9.324600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.459900E-02 |
| Normal-vs-Female |
1.8019999999952E-05 |
| Male-vs-Female |
5.162400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.511200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.180370E-03 |
| Normal-vs-Age(61-80Yrs) |
1.155830E-02 |
| Normal-vs-Age(81-100Yrs) |
3.296800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.004300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.408410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.343800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.833800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.277800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.589600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.409800E-02 |
| Normal-vs-Grade 2 |
1.188670E-04 |
| Normal-vs-Grade 3 |
7.095900E-02 |
| Normal-vs-Grade 4 |
9.860800E-01 |
| Grade 1-vs-Grade 2 |
2.028000E-01 |
| Grade 1-vs-Grade 3 |
1.512000E-02 |
| Grade 1-vs-Grade 4 |
2.378100E-02 |
| Grade 2-vs-Grade 3 |
1.258070E-02 |
| Grade 2-vs-Grade 4 |
2.825500E-04 |
| Grade 3-vs-Grade 4 |
1.091790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.23900000048982E-07 |
| Normal-vs-ccB subtype |
1.428000E-01 |
| ccA subtype-vs-ccB subtype |
2.602900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.976700E-03 |
| Normal-vs-N1 |
4.261400E-01 |
| N0-vs-N1 |
8.228400E-01 |
|
|
